Current and novel pharmacologic approaches in advanced heart failure.
O'Connor
C M
CM
Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Gattis
W A
WA
Swedberg
K
K
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D004232:Diuretics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D015996:Survival Rate; D013565:Sympatholytics / Q000627:therapeutic use*; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use*
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002316:Cardiotonic Agents; D004232:Diuretics; D013565:Sympatholytics; D014665:Vasodilator Agents